HRT, Menopause, and the Brain: New Data
A large UK Biobank analysis examines how menopause and hormone therapy relate to mental health, cognition, and brain structure in midlife women.
-
By
-
Margery Weinstein
-
February 2, 2026
-
Clinical Scorecard: HRT, Menopause, and the Brain: New Data
At a Glance
| Category | Detail |
|---|
| Condition | Menopause and its impact on mental health and brain structure |
| Key Mechanisms | Association of menopause with reduced gray matter volume and increased mental health issues |
| Target Population | Women aged 40 to 69 years, particularly postmenopausal |
| Care Setting | Clinical settings focusing on mental health and menopause management |
Key Highlights
Guideline-Based Recommendations
Diagnosis
Management
- Monitor mental health symptoms in postmenopausal women, especially those on HRT.
- Evaluate the necessity of antidepressant or anxiolytic medications based on symptom severity and duration.
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Postmenopausal women, particularly those considering or using HRT.
HRT may not improve mental health outcomes and could be associated with greater psychiatric symptoms.
Clinical Best Practices
- Evaluate the mental health status of postmenopausal women before initiating HRT, including a review of any pre-existing conditions.
References
